The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liposomal DDS Technology Market Research Report 2025
Synopsis
The global Liposomal DDS Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Liposomal DDS Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Liposomal DDS Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Liposomal DDS Technology in Fungal Infection Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Liposomal DDS Technology include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Liposomal DDS Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal DDS Technology.
Report Scope
The Liposomal DDS Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposomal DDS Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal DDS Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal DDS Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Liposomal DDS Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Liposomal DDS Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Liposomal DDS Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Liposomal DDS Technology in Fungal Infection Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Liposomal DDS Technology include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, Sigma-Tau, Ipsen (Onivyde), CSPC and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Liposomal DDS Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal DDS Technology.
Report Scope
The Liposomal DDS Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposomal DDS Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal DDS Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal DDS Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal DDS Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomal DDS Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal DDS Technology Market Perspective (2019-2030)
2.2 Liposomal DDS Technology Growth Trends by Region
2.2.1 Global Liposomal DDS Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liposomal DDS Technology Historic Market Size by Region (2019-2024)
2.2.3 Liposomal DDS Technology Forecasted Market Size by Region (2025-2030)
2.3 Liposomal DDS Technology Market Dynamics
2.3.1 Liposomal DDS Technology Industry Trends
2.3.2 Liposomal DDS Technology Market Drivers
2.3.3 Liposomal DDS Technology Market Challenges
2.3.4 Liposomal DDS Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal DDS Technology Players by Revenue
3.1.1 Global Top Liposomal DDS Technology Players by Revenue (2019-2024)
3.1.2 Global Liposomal DDS Technology Revenue Market Share by Players (2019-2024)
3.2 Global Liposomal DDS Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liposomal DDS Technology Revenue
3.4 Global Liposomal DDS Technology Market Concentration Ratio
3.4.1 Global Liposomal DDS Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal DDS Technology Revenue in 2023
3.5 Liposomal DDS Technology Key Players Head office and Area Served
3.6 Key Players Liposomal DDS Technology Product Solution and Service
3.7 Date of Enter into Liposomal DDS Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal DDS Technology Breakdown Data by Type
4.1 Global Liposomal DDS Technology Historic Market Size by Type (2019-2024)
4.2 Global Liposomal DDS Technology Forecasted Market Size by Type (2025-2030)
5 Liposomal DDS Technology Breakdown Data by Application
5.1 Global Liposomal DDS Technology Historic Market Size by Application (2019-2024)
5.2 Global Liposomal DDS Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liposomal DDS Technology Market Size (2019-2030)
6.2 North America Liposomal DDS Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liposomal DDS Technology Market Size by Country (2019-2024)
6.4 North America Liposomal DDS Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal DDS Technology Market Size (2019-2030)
7.2 Europe Liposomal DDS Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liposomal DDS Technology Market Size by Country (2019-2024)
7.4 Europe Liposomal DDS Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomal DDS Technology Market Size (2019-2030)
8.2 Asia-Pacific Liposomal DDS Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liposomal DDS Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific Liposomal DDS Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomal DDS Technology Market Size (2019-2030)
9.2 Latin America Liposomal DDS Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liposomal DDS Technology Market Size by Country (2019-2024)
9.4 Latin America Liposomal DDS Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal DDS Technology Market Size (2019-2030)
10.2 Middle East & Africa Liposomal DDS Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liposomal DDS Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa Liposomal DDS Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Liposomal DDS Technology Introduction
11.1.4 Gilead Sciences Revenue in Liposomal DDS Technology Business (2019-2024)
11.1.5 Gilead Sciences Recent Development
11.2 Pacira
11.2.1 Pacira Company Detail
11.2.2 Pacira Business Overview
11.2.3 Pacira Liposomal DDS Technology Introduction
11.2.4 Pacira Revenue in Liposomal DDS Technology Business (2019-2024)
11.2.5 Pacira Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Detail
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Liposomal DDS Technology Introduction
11.3.4 Sun Pharmaceutical Revenue in Liposomal DDS Technology Business (2019-2024)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Liposomal DDS Technology Introduction
11.4.4 Johnson & Johnson Revenue in Liposomal DDS Technology Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Luye Pharma
11.5.1 Luye Pharma Company Detail
11.5.2 Luye Pharma Business Overview
11.5.3 Luye Pharma Liposomal DDS Technology Introduction
11.5.4 Luye Pharma Revenue in Liposomal DDS Technology Business (2019-2024)
11.5.5 Luye Pharma Recent Development
11.6 Sigma-Tau
11.6.1 Sigma-Tau Company Detail
11.6.2 Sigma-Tau Business Overview
11.6.3 Sigma-Tau Liposomal DDS Technology Introduction
11.6.4 Sigma-Tau Revenue in Liposomal DDS Technology Business (2019-2024)
11.6.5 Sigma-Tau Recent Development
11.7 Ipsen (Onivyde)
11.7.1 Ipsen (Onivyde) Company Detail
11.7.2 Ipsen (Onivyde) Business Overview
11.7.3 Ipsen (Onivyde) Liposomal DDS Technology Introduction
11.7.4 Ipsen (Onivyde) Revenue in Liposomal DDS Technology Business (2019-2024)
11.7.5 Ipsen (Onivyde) Recent Development
11.8 CSPC
11.8.1 CSPC Company Detail
11.8.2 CSPC Business Overview
11.8.3 CSPC Liposomal DDS Technology Introduction
11.8.4 CSPC Revenue in Liposomal DDS Technology Business (2019-2024)
11.8.5 CSPC Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Detail
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Liposomal DDS Technology Introduction
11.9.4 Teva Pharmaceutical Revenue in Liposomal DDS Technology Business (2019-2024)
11.9.5 Teva Pharmaceutical Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Liposomal DDS Technology Introduction
11.10.4 Novartis Revenue in Liposomal DDS Technology Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Fudan-Zhangjiang
11.11.1 Fudan-Zhangjiang Company Detail
11.11.2 Fudan-Zhangjiang Business Overview
11.11.3 Fudan-Zhangjiang Liposomal DDS Technology Introduction
11.11.4 Fudan-Zhangjiang Revenue in Liposomal DDS Technology Business (2019-2024)
11.11.5 Fudan-Zhangjiang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Liposomal DDS Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liposomal Doxorubicin
Table 3. Key Players of Liposomal Amphoteracin B
Table 4. Key Players of Liposomal Paclitaxel
Table 5. Key Players of Others
Table 6. Global Liposomal DDS Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Liposomal DDS Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Liposomal DDS Technology Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Liposomal DDS Technology Market Share by Region (2019-2024)
Table 10. Global Liposomal DDS Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Liposomal DDS Technology Market Share by Region (2025-2030)
Table 12. Liposomal DDS Technology Market Trends
Table 13. Liposomal DDS Technology Market Drivers
Table 14. Liposomal DDS Technology Market Challenges
Table 15. Liposomal DDS Technology Market Restraints
Table 16. Global Liposomal DDS Technology Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Liposomal DDS Technology Market Share by Players (2019-2024)
Table 18. Global Top Liposomal DDS Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal DDS Technology as of 2023)
Table 19. Ranking of Global Top Liposomal DDS Technology Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Liposomal DDS Technology Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Liposomal DDS Technology Product Solution and Service
Table 23. Date of Enter into Liposomal DDS Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liposomal DDS Technology Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Liposomal DDS Technology Revenue Market Share by Type (2019-2024)
Table 27. Global Liposomal DDS Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Liposomal DDS Technology Revenue Market Share by Type (2025-2030)
Table 29. Global Liposomal DDS Technology Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Liposomal DDS Technology Revenue Market Share by Application (2019-2024)
Table 31. Global Liposomal DDS Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Liposomal DDS Technology Revenue Market Share by Application (2025-2030)
Table 33. North America Liposomal DDS Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Liposomal DDS Technology Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Liposomal DDS Technology Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Liposomal DDS Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Liposomal DDS Technology Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Liposomal DDS Technology Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Liposomal DDS Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Liposomal DDS Technology Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Liposomal DDS Technology Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Liposomal DDS Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Liposomal DDS Technology Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Liposomal DDS Technology Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Liposomal DDS Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Liposomal DDS Technology Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Liposomal DDS Technology Market Size by Country (2025-2030) & (US$ Million)
Table 48. Gilead Sciences Company Detail
Table 49. Gilead Sciences Business Overview
Table 50. Gilead Sciences Liposomal DDS Technology Product
Table 51. Gilead Sciences Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 52. Gilead Sciences Recent Development
Table 53. Pacira Company Detail
Table 54. Pacira Business Overview
Table 55. Pacira Liposomal DDS Technology Product
Table 56. Pacira Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 57. Pacira Recent Development
Table 58. Sun Pharmaceutical Company Detail
Table 59. Sun Pharmaceutical Business Overview
Table 60. Sun Pharmaceutical Liposomal DDS Technology Product
Table 61. Sun Pharmaceutical Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 62. Sun Pharmaceutical Recent Development
Table 63. Johnson & Johnson Company Detail
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Liposomal DDS Technology Product
Table 66. Johnson & Johnson Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Luye Pharma Company Detail
Table 69. Luye Pharma Business Overview
Table 70. Luye Pharma Liposomal DDS Technology Product
Table 71. Luye Pharma Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 72. Luye Pharma Recent Development
Table 73. Sigma-Tau Company Detail
Table 74. Sigma-Tau Business Overview
Table 75. Sigma-Tau Liposomal DDS Technology Product
Table 76. Sigma-Tau Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 77. Sigma-Tau Recent Development
Table 78. Ipsen (Onivyde) Company Detail
Table 79. Ipsen (Onivyde) Business Overview
Table 80. Ipsen (Onivyde) Liposomal DDS Technology Product
Table 81. Ipsen (Onivyde) Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 82. Ipsen (Onivyde) Recent Development
Table 83. CSPC Company Detail
Table 84. CSPC Business Overview
Table 85. CSPC Liposomal DDS Technology Product
Table 86. CSPC Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 87. CSPC Recent Development
Table 88. Teva Pharmaceutical Company Detail
Table 89. Teva Pharmaceutical Business Overview
Table 90. Teva Pharmaceutical Liposomal DDS Technology Product
Table 91. Teva Pharmaceutical Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 92. Teva Pharmaceutical Recent Development
Table 93. Novartis Company Detail
Table 94. Novartis Business Overview
Table 95. Novartis Liposomal DDS Technology Product
Table 96. Novartis Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Fudan-Zhangjiang Company Detail
Table 99. Fudan-Zhangjiang Business Overview
Table 100. Fudan-Zhangjiang Liposomal DDS Technology Product
Table 101. Fudan-Zhangjiang Revenue in Liposomal DDS Technology Business (2019-2024) & (US$ Million)
Table 102. Fudan-Zhangjiang Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liposomal DDS Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Liposomal DDS Technology Market Share by Type: 2023 VS 2030
Figure 3. Liposomal Doxorubicin Features
Figure 4. Liposomal Amphoteracin B Features
Figure 5. Liposomal Paclitaxel Features
Figure 6. Others Features
Figure 7. Global Liposomal DDS Technology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Liposomal DDS Technology Market Share by Application: 2023 VS 2030
Figure 9. Fungal Infection Therapy Case Studies
Figure 10. Cancer & Tumor Therapy Case Studies
Figure 11. Others Case Studies
Figure 12. Liposomal DDS Technology Report Years Considered
Figure 13. Global Liposomal DDS Technology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Liposomal DDS Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Liposomal DDS Technology Market Share by Region: 2023 VS 2030
Figure 16. Global Liposomal DDS Technology Market Share by Players in 2023
Figure 17. Global Top Liposomal DDS Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal DDS Technology as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Liposomal DDS Technology Revenue in 2023
Figure 19. North America Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Liposomal DDS Technology Market Share by Country (2019-2030)
Figure 21. United States Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Liposomal DDS Technology Market Share by Country (2019-2030)
Figure 25. Germany Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Liposomal DDS Technology Market Share by Region (2019-2030)
Figure 33. China Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Liposomal DDS Technology Market Share by Country (2019-2030)
Figure 41. Mexico Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Liposomal DDS Technology Market Share by Country (2019-2030)
Figure 45. Turkey Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Liposomal DDS Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Gilead Sciences Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 48. Pacira Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 51. Luye Pharma Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 52. Sigma-Tau Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 53. Ipsen (Onivyde) Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 54. CSPC Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 57. Fudan-Zhangjiang Revenue Growth Rate in Liposomal DDS Technology Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
